Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease

Atherosclerosis

Volumn 161, Issue 2, 2002, Pages 261-267

  Merlo, Christoph ^a   Wuillemin, Walter A ^a,b   Redondo, Maurice ^a   Furlan, Miha ^a   Sulzer, Irmela ^a   Kremer Hovinga, Johanna ^a   Binder, Bernd R ^c   Lämmle, Bernhard ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Division of Hematology   (Switzerland)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Contact phase activation; Factor XI; High molecular weight kininogen; Myocardial infarction; Prekallikrein

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH MOLECULAR WEIGHT KININOGEN; NITRATE; PREKALLIKREIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FACTOR XI; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREKALLIKREIN; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 0036119130     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00666-9     Document Type: Article

References (40)

1. Surface-mediated defense reactions. The plasma contact activation system
2. The coagulation-kinin pathway of human plasma
3. Mechanism of activation of bovine factor XI by factor XII and factor XIIa
4. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein
5. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma
6. Association of factor XI and high molecular weight kininogen in human plasma
7. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal plasma and after cold-dependent activation
8. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death
9. The pathogenesis of coronary artery disease and the acute coronary syndromes: Part 2
10. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park heart study
11. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
12. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men
13. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease
14. Activation of human factor VII in plasma and in purified systems. Roles of activated factor XI, kallikrein, and activated factor XII
15. 1-antitrypsin in plasma, a contact phase-activated coagulation factor-inhibitor complex, in patients with coronary artery disease
16. Risk of coronary heart disease and activation of factor XII in middle-aged men
17. Levels of activated FXII in survivors of myocardial infarction - Association with circulating risk factors and extent of coronary artery disease
18. Hyperprolactinemia and reduction in plasma titers of Hageman factor, prekallikrein, and high molecular weight kininogen in patients with acute myocardial infarction
19. Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris
20. Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers
21. Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris
22. Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2)
23. Augmented Hageman factor and prolactin titers, enhanced cold activation of factor VII, and spontaneous shortening of prothrombin time in survivors of myocardial infarction
24. Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgery
25. Factor XII clotting activity and antigen levels in patients with thromboembolic disease
26. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein 'like' activity in human plasma
27. A quantitative dot immunobinding assay for coagulation factor XII in plasma
28. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
29. Multiple significance tests: The Bonferroni method
30. Contact phase of blood coagulation in diabetes mellitus
31. The contact phase of blood coagulation in diabetes mellitus and in patients with vasculopathy
32. Plasma prekallikrein activity in human diabetes mellitus
33. Hageman factor and risk of myocardial infarction in middle-aged men
34. Myocardial infarction in a patient with a Hageman (factor XII) defect
35. Myocardial infarction associated with severe factor XII deficiency
36. Congenital deficiency of Hageman factor (clotting factor XII). Report on the first two families found in Switzerland
37. Defective intrinsic fibrinolytic activity in a patient with severe factor XII-deficiency and myocardial infarction
38. Myocardial infarction with normal coronary arteries and factor XII deficiency
39. Fletcher factor deficiency and myocardial infarction
40. Structural biology, cellular interactions and pathophysiology of the contact system